Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-nmvwc Total loading time: 0 Render date: 2024-06-29T00:43:48.029Z Has data issue: false hasContentIssue false

Chapter 4 - Co-occurring Mental Health Conditions in Pregnant Women with Opioid Use Disorders

from Section 1 - Substance Use Disorders in Women and Pregnancy

Published online by Cambridge University Press:  08 June 2018

By
Alexis S. Hammond  and
Margaret S. Chisolm
Edited by
Tricia E. Wright
Tricia E. Wright
Affiliation:
University of Hawaii, Manoa
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Opioid-Use Disorders in Pregnancy
Management Guidelines for Improving Outcomes
 , pp. 27 - 34
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

McHugh, P. R. and Slavney, P. R. The Perspectives of Psychiatry. Baltimore: JHU Press; 2011.Google Scholar
Vesga-Lopez, O., Blanco, C., Keyes, K., et al. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 2008; 65:805–15.Google Scholar
Leigh, B. and Milgrom, J. Risk factors for antenatal depression, postnatal depression and parenting stress. BMC Psychiatry 2008; 8:24.Google Scholar
Marcus, S. M. and Heringhausen, J. E. Depression in childbearing women: When depression complicates pregnancy. Prim Care: Clin Office Practice 2009; 36:151–65.CrossRefGoogle ScholarPubMed
Norhayati, M., Hazlina, N. N., Asrenee, A., Emilin, W. W. Magnitude and risk factors for postpartum symptoms: A literature review. J Affect Disord 2015; 175:34–52.CrossRefGoogle ScholarPubMed
Biaggi, A., Conroy, S., Pawlby, S., Pariante, C. M. Identifying the women at risk of antenatal anxiety and depression: A systematic review. J Affect Disord 2016; 191:62–77.Google Scholar
Kennare, R., Heard, A., Chan, A. Substance use during pregnancy: Risk factors and obstetric and perinatal outcomes in South Australia. Austral New Zeal J Obstet Gynaecol 2005; 45:220–5.Google Scholar
Krans, E. E., Cochran, G., Bogen, D. L. Caring for opioid-dependent pregnant women: Prenatal and postpartum care considerations. Clin Obstet Gynecol 2015; 58:370–9.Google Scholar
Benningfield, M. M., Arria, A. M., Kaltenbach, K., et al. Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict 2010; 19:416–21.Google Scholar
American Psychiatric Association. Use of the Manual. In: American Psychiatric Association, editors. Diagnostic and Statistical Manual of Mental Disorders. Arlington http://dx.doi.org/10.1176/appi.books.9780890425596.UseofDSM5; 2013. p. 19.Google Scholar
Chisolm, M. S. and Lyketsos, C. G. Systematic Psychiatric Evaluation: A Step-by-Step Guide to Applying the Perspectives of Psychiatry. Baltimore: JHU Press; 2012.Google Scholar
Kavanagh, D. J. Recent developments in expressed emotion and schizophrenia. Br J Psychiatry 1992; 160:601–20.Google Scholar
VanderWeele, T. J., Li, S., Tsai, A. C., Kawachi, I. Association between religious service attendance and lower suicide rates among US women. JAMA Psychiatry 2016; 73:845–51.CrossRefGoogle ScholarPubMed
Chisolm, M. S. and Payne, J. L. Management of psychotropic drugs during pregnancy. BMJ 2016; 532:h5918.Google Scholar
Bolea-Alamanac, B. M., Green, A., Verma, G., Maxwell, P., Davies, S. J. Methylphenidate use in pregnancy and lactation: A systematic review of evidence. Br J Clin Pharmacol 2014; 77:96–101.CrossRefGoogle ScholarPubMed
Dadashova, R. and Silverstone, P. H. Off-label use of atomoxetine in adults: Is it safe? Ment Illn 2012; 4:e19.Google Scholar
Hærvig, K. B., Mortensen, L. H., Hansen, A. V., Strandberg-Larsen, K. Use of ADHD medication during pregnancy from 1999 to 2010: A Danish register-based study. Pharmacoepidemiol Drug Saf 2014; 23:526–33.Google Scholar
Pottegård, A., Hallas, J., Andersen, J. T., et al. First-trimester exposure to methylphenidate: A population-based cohort study. J Clin Psychiatry 2014; 75:88–93.Google Scholar
Chandler, M. Psychotherapy for adult attention deficit/hyperactivity disorder: A comparison with cognitive behaviour therapy. J Psychiatr Ment Health Nurs 2013; 20:814–20.Google Scholar
Manos, M. J. Psychosocial therapy in the treatment of adults with attention-deficit/hyperactivity disorder. Postgrad Med 2013; 125:51–64.CrossRefGoogle ScholarPubMed
Grote, N. K., Bridge, J. A., Gavin, A. R., et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010; 67:1012–24.Google Scholar
Jones, H. Caring for the Dually Diagnosed Patient. In: Jones, Hendrée and Kaltenbach, Karol, editors. Treating Women with Substance use Disorders during Pregnancy: A Comprehensive Approach to Caring for Mother and Child. New York: Oxford University Press; 2013. p. 111–28.Google Scholar
Addis, A. and Koren, G. Safety of fluoxetine during the first trimester of pregnancy: A meta-analytical review of epidemiological studies. Psychol Med 2000; 30:89–94.CrossRefGoogle ScholarPubMed
Einarson, T. R. and Einarson, A. Newer antidepressants in pregnancy and rates of major malformations: A meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 2005; 14:823–7.Google Scholar
O'Brien, L., Einarson, T. R., Sarkar, M., Einarson, A., Koren, G. Does paroxetine cause cardiac malformations? J Obstet Gynaecol Can 2008; 30:696–701.Google Scholar
Rahimi, R., Nikfar, S., Abdollahi, M. Pregnancy outcomes following exposure to serotonin reuptake inhibitors: A meta-analysis of clinical trials. Reprod Toxicol 2006; 22:571–5.CrossRefGoogle ScholarPubMed
Davis, R. L., Rubanowice, D., McPhillips, H., et al. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf 2007; 16:1086–94.Google Scholar
Nulman, I., Rovet, J., Stewart, D. E., et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997; 336:258–62.Google Scholar
Simon, G. E., Cunningham, M. L., Davis, R. L. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002; 159:2055–61.Google Scholar
Ramos, E., St-Andre, M., Rey, E., Oraichi, D., Berard, A. Duration of antidepressant use during pregnancy and risk of major congenital malformations. Br J Psychiatry 2008; 192:344–50.Google Scholar
Byatt, N., Deligiannidis, K. M., Freeman, M. P. Antidepressant use in pregnancy: A critical review focused on risks and controversies. Acta Psychiatr Scand 2013; 127:94–114.Google Scholar
Yonkers, K. A., Blackwell, K. A., Glover, J., Forray, A. Antidepressant use in pregnant and postpartum women. Annu Rev Clin Psychol 2014; 10:369–92.CrossRefGoogle ScholarPubMed
Chambers, C. D., Hernandez-Diaz, S., Van Marter, L. J., et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006; 354:579–87.CrossRefGoogle ScholarPubMed
Hofmann, S. G., Asnaani, A., Vonk, I. J., Sawyer, A. T., Fang, A. The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cogn TherRes 2012; 36:427–40.Google Scholar
Viguera, A. C., Nonacs, R., Cohen, L. S., et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000; 157:179–84.CrossRefGoogle ScholarPubMed
Viguera, A. C., Whitfield, T., Baldessarini, R. J., et al. Risk of recurrence in women with bipolar disorder during pregnancy: Prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007; 164:1817–24.CrossRefGoogle ScholarPubMed
Dolk, H., Jentink, J., Loane, M., Morris, J., de Jong-van den Berg, L. T., EUROCAT Antiepileptic Drug Working Group. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology 2008; 71:714–22.Google Scholar
Clark, C. T., Klein, A. M., Perel, J. M., Helsel, J., Wisner, K. L. Lamotrigine dosing for pregnant patients with bipolar disorder. Am J Psychiatry 2013; 170:1240–7.CrossRefGoogle ScholarPubMed
Pearlstein, T. Use of psychotropic medication during pregnancy and the postpartum period. Womens Health 2013; 9:605–15.Google Scholar
Cohen, L. S., Friedman, J., Jefferson, J. W., Johnson, E. M., Weiner, M. L. A reevaluation of risk of in utero exposure to lithium. JAMA 1994; 271:146–50.Google ScholarPubMed
Black, R. A. and Hill, D. A. Over-the-counter medications in pregnancy. Am Fam Physician 2003; 67:2517–24.Google Scholar
Gilboa, S. M., Ailes, E. C., Rai, R. P., Anderson, J. A., Honein, M. A. Antihistamines and birth defects: A systematic review of the literature. Expert Opin Drug Saf 2014; 13:1667–98.Google Scholar
Okun, M. L., Ebert, R., Saini, B. A review of sleep-promoting medications used in pregnancy. Obstet Gynecol 2015; 212:428–41.Google ScholarPubMed
Iqbal, M. M., Sobhan, T., Ryals, T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv 2002; 53:39–49.Google Scholar
Lin, A. E., Peller, A. J., Westgate, M., et al. Clonazepam use in pregnancy and the risk of malformations. Birth Defects Res Part A: Clin Mol Teratol 2004; 70:534–6.Google Scholar
Wang, L., Lin, H., Lin, C., Chen, Y. Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy. Clin Pharmacol Ther 2010; 88:369–74.CrossRefGoogle ScholarPubMed
Smith, M. T., Huang, M. I., Manber, R. Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. Clin Psychol Rev 2005; 25:559–92.CrossRefGoogle ScholarPubMed
Taylor, D. J. and Pruiksma, K. E. Cognitive and behavioural therapy for insomnia (CBT-I) in psychiatric populations: A systematic review. Int Rev Psychiatry 2014; 26:205–13.Google Scholar
Martin, P. R., Arria, A. M., Fischer, G., et al. Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict 2009; 18:148–56.Google Scholar
Zweben, J. Special Issues in Treatment: Women. In: Ries, Richard, Miller, Shannon, Fiellin, David and Saitz, Richard, editors. The ASAM Principles of Addiction Medicine, Fifth Edition. Hong Kong: Wolters Kluwer Health; 2014. p. 524–34.Google Scholar
Holmes, L. B. and Hernandez-Diaz, S. Newer anticonvulsants: Lamotrigine, topiramate and gabapentin. Birth Defects Res Part A: Clin Mol Teratol 2012; 94:599–606.CrossRefGoogle ScholarPubMed
Mølgaard-Nielsen, D. and Hviid, A. Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA 2011; 305:1996–2002.CrossRefGoogle ScholarPubMed
Fujii, H., Goel, A., Bernard, N., et al. Pregnancy outcomes following gabapentin use: Results of a prospective comparative cohort study. Neurology 2013; 80:1565–70.CrossRefGoogle ScholarPubMed
Harrop, E. N. and Marlatt, G. A. The comorbidity of substance use disorders and eating disorders in women: Prevalence, etiology, and treatment. Addict Behav 2010; 35:392–8.Google Scholar
Gregorowski, C., Seedat, S., Jordaan, G. P. A clinical approach to the assessment and management of co-morbid eating disorders and substance use disorders. BMC Psychiatry 2013; 13:1.CrossRefGoogle Scholar
Cardwell, M. S. Eating disorders during pregnancy. Obstet Gynecol Surv 2013; 68:312–23.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×